INM 8-K: Acquisition
InMed Pharmaceuticals Inc. completed its previously
Filed with the SEC on · accession 0001193125-26-452706
INM filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
InMed Pharmaceuticals Inc. completed its previously disclosed merger with Mentari Therapeutics, Inc. and changed its name to Mentari Therapeutics, Inc., with its common stock now trading under the symbol MTRI on Nasdaq.
Key details
✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INM?
Click hereFrequently asked questions
What did INM file with the SEC on Nov 9, 2026?
INM filed a 8-K (Acquisition). InMed Pharmaceuticals Inc. completed its previously disclosed merger with Mentari Therapeutics, Inc. and changed its name to Mentari Therapeutics, Inc., with its common stock now trading under the symbol MTRI on Nasdaq.
What does a acquisition mean for INM stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other INM SEC filings
- 8-K · Stock splitNov 5, 2026
- 8-K · Stock splitNov 5, 2026
- 10-Q · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- 424B3 · Material agreementOct 28, 2026
- SCHEDULE 13G/A · SEC filingOct 7, 2026
- EFFECT · Shelf registrationOct 1, 2026
- S-4 · SEC filingSep 29, 2026
- 8-K · Delisting noticeSep 18, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days